SCHEMBL6580653

SCHEMBL6580653

CC(Cl)OC(=O)OC1COCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29143308 0.93
SCHEMBL6578416 0.82
SCHEMBL30313871 0.79 MEN1 (0.31)
SCHEMBL14351517 0.79
SCHEMBL6580932 0.79 KAT2B (0.35)
SCHEMBL6941234 0.78 EPHX1 (0.31)
SCHEMBL27280420 0.76 EPHX1 (0.35)
SCHEMBL5497437 0.76 EPHX1 (0.39)
SCHEMBL14996233 0.75 CYP1A2 (0.30)
SCHEMBL654885 0.74 EPHX1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331528-B1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS MERCK SHARP & DOHME (US) 2020-05-27 EP disclosed
US-8859529-B2 Compounds for the treatment of inflammatory disorders MERCK SHARP & DOHME CORP. (US) 2014-10-14 US disclosed
US-8859529-B2 Compounds for the treatment of inflammatory disorders MERCK SHARP & DOHME CORP. (US) 2014-10-14 US disclosed
US-20110288054-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2011-11-24 US disclosed
US-20040248941-A1 Benzimidazone compound, process for producing the same, and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-09 US disclosed
EP-1437352-A1 BENZIMIDAZOLE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed